DB
Therapeutic Areas
Coherent Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CBP-1008 | Ovarian Cancer (including Clear Cell Carcinoma) | Pivotal Trials |
| CBP-1018 | Prostate Cancer (mCRPC) | Phase 1/2 |
| CBP-1019 | Oncology (vs. TOP1 inhibitor ADCs) | Phase 1/2 |
| Bi-XDC with PROTACs | Oncology | IND-enabling |
| Bi-XDC with RPT | Oncology | Early-stage |